Sinopharm Group Co Ltd
SWB:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
SWB:X2S
|
CN |
|
Novartis AG
OTC:NVSEF
|
CH |
|
T
|
Trillion Energy International Inc
CNSX:TCF
|
CA |
|
H
|
Hologic Inc
F:HO1
|
US |
|
O
|
Oil India Ltd
BSE:533106
|
IN |
|
M
|
Meridian Energy Ltd
ASX:MEZ
|
NZ |
|
Nisshin OilliO Group Ltd
TSE:2602
|
JP |
|
Moneymax Financial Services Ltd
SGX:5WJ
|
SG |
|
A
|
Atos SE
DUS:AXI
|
FR |
|
Cigna Corp
NYSE:CI
|
US |
|
JBM Auto Ltd
NSE:JBMA
|
IN |
|
InvoCare Ltd
ASX:IVC
|
AU |
|
Wolters Kluwer NV
AEX:WKL
|
NL |
|
AngloGold Ashanti Ltd
NYSE:AU
|
ZA |
|
A
|
Atlanta Braves Holdings Inc
NASDAQ:BATRA
|
US |
|
Lithia Motors Inc
NYSE:LAD
|
US |
|
Shanghai International Port Group Co Ltd
SSE:600018
|
CN |
|
A
|
Archean Chemical Industries Ltd
NSE:ACI
|
IN |
|
W
|
Western Uranium & Vanadium Corp
CNSX:WUC
|
CA |
|
Medifast Inc
NYSE:MED
|
US |
|
Stora Enso Oyj
F:ENUA
|
FI |
|
IAR Systems Group AB
F:NC91
|
SE |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XBER:ME9
|
IT |
|
Sakura Internet Inc
TSE:3778
|
JP |
Wall St Price Targets
X2S Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for X2S is 2.5399 EUR with a low forecast of 1.8906 EUR and a high forecast of 3.1182 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
2.5399
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 2.5399 EUR with a low forecast of 1.8906 EUR and a high forecast of 3.1182 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.
